LGG-08. TREATMENT OUTCOMES AND TOLERABILITY OF TRAMETINIB IN PROGRESSIVE CIRCUMSCRIBED LOW-GRADE GLIOMAS

Circumscribed low-grade gliomas comprise roughly one-third of pediatric CNS tumors. Most of these tumors are caused by activating mutations in the mitogen-activated protein kinase (MAPK) pathway. Drugs targeting the MAPK pathway are effective in other cancers and are being utilized in low-grade glio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Hanzlik, Emily, Archambault, Bridget, Dairi, Mays, Schroeder, Kristin, Patel, Mallika, Lipp, Eric S, Boucree, Song, Peters, Katherine, Ashley, David, Landi, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2021
Aiheet:
Low Grade Gliomas
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168132/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noab090.132
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia